MYGN FY 2009 Earnings — Myriad Genetics, Inc. Revenue & Financial Results | Market Cap Arena

MYGNMyriad Genetics, Inc.

$473M

FY 2009 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$363M+11.1% YoY

Gross Profit

$318M87.8% margin

Operating Income

$135M37.2% margin

Net Income

$152M42.0% margin

EPS (Diluted)

$1.54

Cash Flow

Operating Cash Flow

$155M

Free Cash Flow

$147M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$594M

Total Liabilities

$36M

Stockholders' Equity

$558M

Cash & Equivalents

$93M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$363M	$327M	+11.1%
Gross Profit	$318M	$283M	+12.4%
Operating Income	$135M	$126M	+6.8%
Net Income	$152M	$85M	+80.0%